PsychoPharmacology News
by Circle Of Insight Productions
CYP450 Drug Interactions: When Psychiatric Medications Change Each…
About this podcast
Psychopharmacology: Drugs, the Brain & Behavior explores what medications actually do to the brain—and what the research really says about their benefits, risks, controversies, and unexpected effects. Hosted by psychologist Dr. Carlos Vazquez, each episode examines a medication, drug class, emerging treatment, or provocative new study through the science of pharmacology, neuroscience, and human behavior.
From antidepressants, stimulants, antipsychotics, lithium, and anxiety medications to ketamine, psychedelics, addiction treatments, pharmacogenetics, and emerging drugs, the podcast goes beyond headlines to explain mechanisms of action and the evidence behind them. You’ll also hear occasional foundational episodes explaining receptors, neurotransmitters, drug classes, side effects, tolerance, withdrawal, and other concepts that make psychopharmacology easier to understand.
Whether you’re a psychologist, therapist, student, healthcare professional, or simply fascinated by how drugs change the brain, Psychopharmacology: Drugs, the Brain & Behavior turns complicated medication science into understandable stories.
For educational purposes only; the podcast does not provide individual medical advice.
Episodes
The newest 50 of 455 episodes
- CYP450 Drug Interactions: When Psychiatric Medications Change Each Other’s Effects · 5 minTwo psychiatric medications may be safe individually but produce unexpected effects when prescribed together. This episode examines how cytochrome P450 enzymes metabolize…
- Methamphetamine and the Brain: Dopamine, Psychosis, and Neurotoxicity · 4 minExplain how methamphetamine affects dopamine transporters, neurotransmitter release, sleep, cognition, and the neural mechanisms associated with addiction and psychosis.
- Rhino Tranq: The New Veterinary Sedative Appearing in America’s Fentanyl Supply · 5 minpowerful veterinary sedative known as medetomidine sometimes called “rhino tranq,” is emerging as another dangerous contaminant in the illicit fentanyl supply. More potent than…
- Norepinephrine: The Brain Chemical Behind Focus, Stress, and Psychiatric Medications · 4 minNorepinephrine plays a central role in attention, motivation, emotional regulation, and the body’s response to stress. This episode explores how disruptions in noradrenergic…
- Why Does One Person Become Addicted to Stimulants While Another Takes Them for ADHD? · 4 minTwo people may take medications that influence the same neurotransmitter systems, yet their psychological and behavioral experiences can be remarkably different. Why do some…
- The Pharmacology of Study Drugs: Amphetamines, Dopamine, and Cognitive Enhancement · 3 minExplore how amphetamine-based medications influence dopamine and norepinephrine signaling, why subjective concentration can differ from measurable cognitive improvement, and how…
- Withdrawal or Relapse? Why Antidepressant Discontinuation Can Be Misunderstood · 4 minExplore the psychological and clinical challenges of distinguishing antidepressant discontinuation symptoms from the return of depression or anxiety. Examine how symptom timing…
- When Addiction Treatment Becomes Addiction Maintenance: The Pharmacology Behind Rehab Fraud · 3 minWhat happens when a facility entrusted with treating substance-use disorders allegedly helps perpetuate the very addiction it promises to address? This episode examines the…
- SSRIs Compared: Best Diagnoses, Half-Lives, Side Effects, and Prescribing Exceptions · 5 minNot every SSRI is interchangeable — choosing the right one depends on far more than just the diagnosis in front of you. This episode compares seven SSRIs across their…
- Dopamine Blockade: Why Antipsychotics Work and Why They Cause Side Effects · 4 minAntipsychotic medications frequently act on dopamine D2 receptors, but blocking these receptors produces different effects depending on where they are located in the brain. This…
- Why Prozac, Zoloft, and Lexapro Affect Patients Differently · 6 minExplore pharmacokinetics, CYP450 metabolism, serotonin transporter inhibition, and receptor adaptations. Explain why medications within the same class can differ in tolerability…
- Why Antidepressants Take Weeks to Work · 5 minExplore serotonin transporters, receptor adaptations, and the differences between immediate medication effects and delayed clinical improvement. Explain why antidepressant…
- Methamphetamine vs. Adderall: How Different Are They Really? · 5 minMethamphetamine and prescription amphetamines share important pharmacological properties, but differences in chemical structure, dosing, delivery, and medical supervision can…
- Why Antidepressants Take Weeks to Work · 5 minExplore serotonin transporters, receptor adaptations, and the differences between immediate medication effects and delayed clinical improvement. Explain why antidepressant…
- Beyond Fentanyl: The Rise of Synthetic Opioids Ten Times More Potent · 3 minA new class of synthetic opioids known as orphine analogues has been detected in illicit drug supplies across 22 American states, raising concerns about the next evolution of the…
- Why Antidepressants Sometimes Stop Working: The Science Behind the Loss of Response · 4 minAntidepressants influence neurotransmission relatively quickly, yet meaningful clinical improvement often takes longer. This episode explores receptor signaling, neural…
- When Antipsychotics Aren’t the Answer: The Medical Illness That Can Look Like Psychosis · 3 minHallucinations, paranoia, agitation, and bizarre behavior can reasonably lead clinicians toward antipsychotic treatment, but what happens when the underlying illness isn’t…
- Why Do SSRIs Take Weeks to Work If They Change Serotonin Within Hours? · 4 minSSRIs begin altering serotonin signaling within hours, yet people with depression or anxiety are often told that meaningful improvement may take weeks. Why does the brain respond…
- Beyond the Daily Pill: The Injection Shaking Up Bipolar Treatment · 3 minA new study published in The American Journal of Psychiatry analyzed electronic health records from 2,086 individuals with bipolar disorder in Hong Kong treated between 2004 and…
- A Simpler Way to Ease OCD When Bipolar Is Also in the Picture · 2 minMany people live with both bipolar disorder and obsessive-compulsive symptoms. The usual medicines for OCD can make bipolar moods swing more wildly. A new study points to a…
- The FDA Is Fast-Tracking Psychedelics. Noribogaine Is the Test Case That Is Not a Trip. · 3 minAfter an executive order pushing HHS to speed mental-health treatments, the FDA issued priority vouchers for psilocybin in depression and methylone in PTSD and cleared the first…
- Know Your Brain: The Four Lobes and What They Actually Do · 17 minThis episode breaks down the brain's four primary lobes — frontal, parietal, temporal, and occipital — and explains, in plain terms, what each one actually does and what happens…
- Psychopharmacology Masterclass: Drug Classes, Mechanisms of Action, and What Every Psychologist Needs to Know for Clinical Practice and the · 17 minPsychopharmacology is one of the most heavily tested and clinically consequential domains in professional psychology, covering everything from the neurochemical mechanisms behind…
- Retracted: The Hepatitis B Vaccine, Autism Claims, and the Challenges of Causation · 7 minIn this episode, we examine the recent retraction of a 2010 study that suggested a link between neonatal hepatitis B vaccination and autism in boys. We break down the…
- Escitalopram for Kids’ Anxiety: FDA Approval or Risky Gamble? Weighing the Evidence” · 8 minIn 2023, the FDA approved escitalopram (Lexapro) for generalized anxiety disorder (GAD) in children aged 7 and older, based largely on one industry-sponsored trial showing a…
- Noribogaine (DMX-1001): A Neuroplastogen Breakthrough for Alcohol Use Disorder or Another Psychedelic Promise with Risks? · 5 minThe FDA accepted DemeRx’s IND for oral noribogaine (DMX-1001) in April 2026, advancing a longer-acting metabolite of ibogaine as a potential treatment for alcohol use disorder…
- Rising Costs in Healthcare: The 2026 Pharmaceutical Price Increases and Their Implications · 5 minI n early 2026, pharmaceutical manufacturers announced list price increases on at least 350 brand-name medications, continuing a pattern that affects treatments for cancer…
- The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 2 · 5 minPart two In the mid-20th century, a handful of chance observations transformed psychiatry from an asylum-bound specialty into a medical field powered by effective drugs. This…
- The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 1 · 4 minIn the mid-20th century, a handful of chance observations transformed psychiatry from an asylum-bound specialty into a medical field powered by effective drugs. This episode…
- Curcumin: Turmeric’s Golden Promise for Blood Sugar and Mood – Evidence, Arguments For and Against · 6 minExplore the 2026 meta-analysis and supporting studies on curcumin for prediabetes, type 2 diabetes, depression, and anxiety, weighing compelling arguments in favor of its use…
- Dextromethorphan ( think cough syrup) for OCD: A Promising Glutamate-Targeted Augmentation Strategy? · 7 minA small 2026 randomized controlled trial found that adding low-dose dextromethorphan (DXM, 15 mg twice daily) to ongoing SSRI treatment significantly reduced Yale-Brown Obsessive…
- Antidepressants and Suicide Prevention: Lessons from Korea’s 2002 Prescription Restrictions · 8 minA recent study examines how South Korea’s 2002 limits on SSRI prescribing by primary care physicians coincided with a striking rise in national suicide rates. This episode…
- Silent Slip: How Medications Are Fueling Falls in Our Elderly · 5 minThis episode explores the alarming link between common medications and falls among older adults, revealing how psychotropics and polypharmacy contribute to up to three-quarters…
- The Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study · 5 minIn the ER, seconds matter when identifying the "Dangerous Tetrad": rigidity, fever, autonomic instability, and altered mentation. This episode breaks down the clinical markers…
- Antidepressant Withdrawal: 50% of Long-Term Users Suffer? Shocking JAMA Study vs Real-World Reality Exposed · 10 minPsychiatrists are clashing over antidepressant withdrawal: clinic data shows up to 50% of long-term SSRI/SRI users face severe symptoms, while a major 2025 JAMA Psychiatry…
- Metabolic Brake or Muscle Catalyst? The Pharmacokinetics of GLP-1 Muscle Loss · 5 minWhile GLP-1 receptor agonists are not inherently "muscle-toxic," the rapid metabolic shift they induce can lead to a catabolic state that consumes lean tissue. In this episode…
- Ibogaine: Miracle Cure or Medical Gamble? The Truth Behind a Controversial Psychedelic · 7 minThis episode explores ibogaine as a controversial psychedelic treatment for addiction, examining its reported effects on opioid withdrawal, cravings, and psychological insight…
- The Messy Truth About Antidepressants: Benefits, Risks, and the Limits of the Evidence · 9 minAntidepressants demonstrate modest but real benefits for moderate-to-severe depression, with large meta-analyses showing consistent advantages over placebo and meaningful…
- Marijuana and emphysema · 2 min
- Ketamine and neurotoxicity · 2 min
- New study on lithium · 2 min








